Rebalance’s Corteva CTVA Stock Holding History

Rebalance’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-638	Closed	-$37.5K	–	86
2022 Q4	$37.5K	Buy	+638	New	+$40.4K	﹤0.01%	113

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Rebalance's CTVA Position: Q1 2023 in Review

Rebalance sold out of Corteva (CTVA) in Q1 2023, closing a stake of 638 shares — an estimated $37.5K sold.

Rebalance first reported a position in CTVA in Q4 2022 and held it in 1 quarter. The position peaked at $37.5K in Q4 2022. 1,252 funds tracked by Wall St. Rank hold CTVA as of Q1 2023.

Rebalance reported no remaining Corteva position as of Q1 2023 after selling out during the quarter.
Rebalance sold 638 Corteva shares in Q1 2023, an estimated $37.5K.
Rebalance first reported a position in Corteva in Q4 2022 and held it in 1 quarter.
Rebalance's Corteva position peaked at $37.5K in Q4 2022.
1,252 funds tracked by Wall St. Rank held Corteva as of Q1 2023.

Based on Rebalance's 13F filing for Q1 2023, filed 3 May 2023.